- VanDeMark has been a Comvest portfolio company since 2019
- Moving forward, Comvest will remain a co-owner of VanDeMark
- King & Spalding LLP acted as legal counsel to SK Capital and Kirkland & Ellis LLP acted as legal counsel to Comvest
SK Capital has made an investment in VanDeMark Chemical Inc, a producer of life science chemistries. No financial terms were disclsosed for the transaction that was done in partnership with Comvest.
VanDeMark has been a platform company in Comvest’s private equity portfolio since 2019. Comvest will remain a co-owner of VanDeMark.
VanDeMark is headquartered in Lockport, New York.
“As we deepen VanDeMark’s product and service offering with a focus on the life science markets, we remain focused on the core competencies and products that have enabled the company’s tenured success,” said Mario Toukan, a managing director of SK Capital, in a statement. “Although VanDeMark is well established, we feel the company’s story is just getting started and see a tremendous opportunity to drive transformation and create a global leader for the provision of a broader set of high-end life science chemistries. Looking forward, we will seek to accelerate the company’s transformation with strategic investments in adjacent portfolios of fine chemistries and additional manufacturing services that can be additive to our existing customers.”
King & Spalding LLP acted as legal counsel to SK Capital and Kirkland & Ellis LLP acted as legal counsel to Comvest. Debt financing was provided by a bank group led by CIT.
SK Capital is focused on the specialty materials, specialty chemicals, and pharmaceuticals sectors. Currently, SK Capital has approximately $6.6 billion of assets under management.
Comvest Partners invests in middle-market companies. Comvest manages more than $7.7 billion in assets, and has invested over $8.7 billion since inception. Based in West Palm Beach, Comvest also maintains offices in Chicago and New York.